Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Intravitreal Bevacizumab for Diabetic Macular Edema

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
Isfahan Ophthalmology Research Center
ClinicalTrials.gov Identifier:
NCT00703235
First received: June 20, 2008
Last updated: NA
Last verified: June 2008
History: No changes posted

June 20, 2008
June 20, 2008
Not Provided
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Intravitreal Bevacizumab for Diabetic Macular Edema
Not Provided

Diabetic macular edema is a common cause of visual loss among diabetic patients. Studies have demonstrated the role of vascular endothelial growth factor (VEGF) in the pathogenesis of edema.

This study designed to evaluate the effect of Intravitreal injection of a recombinant monoclonal anti-VEGF antibody, Bevacizumab, for treatment of diabetic macular edema.

Not Provided
Interventional
Phase 2
Phase 3
Not Provided
  • Macular Edema
  • Diabetic Retinopathy
Drug: Bevacizumab
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Enrolling by invitation
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Diabetes mellitus
  • Clinically significant macular edema
  • Possibility of performing macular OCT
  • Consent of patient for inclusion in the study

Exclusion Criteria:

  • History of macular photocoagulation in less than 6 months of inclusion in the study
  • Necessity of surgical intervention
  • Rejection of the remaining in the study by patient
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00703235
MUI - clinical - 185290
Not Provided
Not Provided
Isfahan Ophthalmology Research Center
Not Provided
Not Provided
Isfahan Ophthalmology Research Center
June 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP